Pharmaceutical Affiliate definition

Pharmaceutical Affiliate means TO Pharmaceuticals LLC., a Delaware limited liability company.
Pharmaceutical Affiliate means Tikun Olam IP Ltd., a Cayman Islands corporation.
Pharmaceutical Affiliate means Tikun Olam IP Ltd., a Cayman Islands corporation. 50. “Pharmaceutical Business” shall have the meaning set forth in the preamble of this Agreement. 51. “Pharmaceutical Product” shall mean any product, compound, medicine or therapeutic which is subject to regulation as a drug, medicine or controlled substance by the FDA. 52. “Receiving Party” shall have the meaning set forth in Section 9 of this Agreement. 53. “Representative” shall mean any director, officer, employee, member, manager, agent, contractor or advisor who shall have access to any Confidential Information. 54. “Residual Information” means any Confidential Information, which may be retained, following the termination of this Agreement, in intangible form in the minds of the Representatives. 55. “Services” shall mean the Training Services, the Design and Operations Services and the Clinical Trials Services. 56. “Shortfall” shall have the meaning set forth in Section 13.3 of this Agreement. 57. “Territory” shall have the meaning set forth in Section 2.1 of this Agreement. 58. “Third-Party Claim” shall have the meaning set forth in Section 13.4 of this Agreement. 59. “Third-Party IP” shall have the meaning set forth in Section 2.9 of this Agreement. 60. “TO LLC” shall have the meaning set forth in Section 2.2 of this Agreement. 61. “TO Strains” shall have the meaning set forth in Section 2.6 of this Agreement. 62. “Training Services” shall have the meaning set forth in Section 7.1(b) of this Agreement. 63. “United States” shall mean the United States of America and its territories and possessions. 64. “USA Payment” shall have the meaning set forth in Section 3 of this Agreement. 65. “US Medical Cannabis License Agreement” shall have the meaning set forth in Section2.2 of this Agreement. 66. “Valuator” shall have the meaning set forth in Section 16.6 of this Agreement.

Examples of Pharmaceutical Affiliate in a sentence

  • In addition, Licensee, together with its Affiliates, the Pharmaceutical Affiliate and TO LLC, or such other Affiliates of Licensee as Licensee may determine, shall pay the aggregate remaining costs in connection with such Clinical Trials, if any.

  • In addition, Licensee, together with its Affiliates, TO LLC and the Pharmaceutical Affiliate, or such other Affiliates of Licensee as Licensee may determine, shall pay the aggregate remaining costs in connection with such Clinical Trials, if any.

  • To the extent not already accomplished, within 120 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, J&J or a J&J Pharmaceutical Affiliate shall send, electronically or in hard copy format, a letter to each entity employing Third Party Personnel.

  • If J&J and/or the J&J Pharmaceutical Affiliates determine (after a reasonable opportunity to conduct an appropriate review or investigation of the allegations) through any means that there is a Reportable Event involving a J&J Pharmaceutical Affiliate, J&J shall notify OIG, in writing, within 30 days after making the determination that the Reportable Event exists.

  • In addition, if there is a change in Federal health care program requirements, FDA requirements, NIH requirements or other applicable requirements relating to registration and results reporting of clinical study information, J&J and/or the applicable J&J Pharmaceutical Affiliate shall fully comply with such requirements.

  • If necessary and appropriate to collect the repayment, J&J or the J&J Pharmaceutical Affiliate shall file suit against the Covered Executive unless good cause exists not to do so.

  • The applicable J&J Pharmaceutical Affiliate shall continue to comply with Federal health care program requirements, or other applicable requirements relating to the registration and results reporting of clinical studies throughout the term of this CIA.

  • Each such Certifying Employee shall annually certify that the applicable J&J or J&J Pharmaceutical Affiliate business unit is compliant with applicable Federal health care program and FDA requirements and with the obligations of this CIA.

  • J&J or the applicable J&J Pharmaceutical Affiliate shall screen all prospective Covered Persons against the Exclusion Lists prior to engaging their services and, as part of the hiring or contracting process, shall require such Covered Persons to disclose whether they are Ineligible Persons.

  • In the event that, after the Effective Date, J&J or a J&J Pharmaceutical Affiliate changes locations or closes a business unit or location related to or engaged in any of the Covered Functions, J&J and/or the J&J Pharmaceutical Affiliates shall notify OIG of this fact as soon as possible, but no later than within 30 days after the date of change or closure of the location.